Clinical Trials Browser

Carcinoma, Hepatocellular × Pravastatin × Clear all

NCT03219372 2021-01-22

Pravastatin Intervention to Delay Hepatocellular Carcinoma Recurrence

Phase 2 Terminated

1 enrolled 5 charts

Gastrointestinal

Carcinoma, Hepatocellular

NCT01075555 2020-03-30

Sorafenib Tosylate With or Without Pravastatin in Treating Patients With Liver Cancer and Cirrhosis

Phase 3 Completed

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT01357486 2017-05-01

PRODIGE 21

Phase 2 Completed

Gastrointestinal

Carcinoma, Hepatocellular